MULTIOMICS AND THERAPY STACKING: Personalized Cancer Care

Dr. Nathan Goodyear was recently featured on Fox News, and on this podcast, he will comment and take a deeper dive on the findings of these new cancer pills that were featured in the article.

 

Personalized medicine is the future available today. With the integration of multiomics in the personalized treatment protocol not only of cancer patients but any chronic disease, the individual as a whole is being considered and the root cause is addressed through personalized and individualized care.

 

Targeted therapies, such as Osimertinib and Ribociclib, mark a significant advancement in cancer treatment. Osimertinib destructively targets abnormal proteins found in some cancers, while Ribociclib counteracts abnormal growth hormones in breast cancer, being used earlier in the treatment process to enhance survival rates. Employing these therapies proactively before recurrences can directly improve patient survival outcomes, revolutionizing cancer treatment.

 

 

*************
To learn more about Dr. Goodyear, visit his website at drgoodyear.com. 

For more interesting videos on a variety of topics, TikTok videos are updated daily at www.tiktok.com/@briomedical and long-form videos can be found on our YouTube Channel www.youtube.com/@BrioMedical.

Patients interested in pursuing their cancer healing journey can visit Dr. Goodyear at Brio Medical in Scottsdale, Arizona by visiting brio-medical.com.